Previous Article | Next Article 
Infection and Immunity, August 2001, p. 4831-4838, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4831-4838.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Demonstration of the Genetic Stability and Temporal Expression of
Select Members of the Lyme Disease Spirochete OspF Protein Family
during Infection in Mice
John V.
McDowell,
Shian Ying
Sung,
Gregory
Price, and
Richard T.
Marconi*
Department of Microbiology and Immunology,
Medical College of Virginia at Virginia Commonwealth University,
Richmond, Virginia 23298-0678
Received 14 December 2000/Returned for modification 28 February
2001/Accepted 15 May 2001
 |
ABSTRACT |
Infection with Lyme disease spirochetes can be chronic. This
suggests that the spirochetes are capable of immune evasion. In a
previous study we demonstrated that the ospE gene family, which is one of three gene families whose members are flanked at their
5' end by the highly conserved upstream homology box (UHB) element,
undergoes mutation and rearrangement during infection. This results in
the generation of antigenically distinct variants that may contribute
to immune evasion. In this study we have assessed the genetic stability
of the UHB-flanked ospF gene family during infection in
mice. Using postinfection clonal populations of Borrelia burgdorferi B31MI, PCR amplicons were generated for three members of the ospF gene family after a 3-month infection time
frame. The amplicons were analyzed by single-nucleotide polymorphism pattern analysis and DNA sequencing. Members of the ospF
gene family were found to be stable during infection, as no mutations or rearrangements were detected. An analysis of the humoral immune response to these proteins during infection revealed that the immune
response to each is specific and that there is a delayed humoral immune
response to some OspF protein family members. These analyses suggest
that there is a temporal component to the expression of these genes
during infection. In addition to a possible contribution to immune
evasion, members of the OspF protein family may play specific roles at
different stages of infection.
 |
INTRODUCTION |
Lyme disease is a chronic infection
caused by certain species of the Borrelia burgdorferi sensu
lato complex. In North America, B. burgdorferi is the
primary species associated with disease in humans. The ability of the
Lyme disease spirochetes to maintain chronic infection indicates that
they are capable of immune evasion. To date, two different genes or
gene families have been implicated in immune evasion, vls
and the ospE gene family (designated family 162 by the
Institute for Genomic Research [TIGR]) (20, 23). Recent
studies have demonstrated that the ospE gene family
undergoes mutation during infection, leading to the generation of OspE
variants that are antigenically distinct from the proteins expressed by the preinfection spirochete population (20). The mutations
that develop in the ospE genes are of two types, point
mutations that alter the amino acid sequence, and recombination events
between ospE alleles that generate polymorphic
OspE-related proteins. The vlsE gene also undergoes mutation
during infection (23). It is thought that vlsE
is involved in unidirectional recombination with a series of
vls pseudogenes, leading to the modification of the
vlsE sequence that is expressed. The resulting variants are
thought to encode antigenically distinct proteins.
The process of immune evasion in the Lyme disease spirochetes, as
mediated by antigenic variation, differs from the well-described system
of the relapsing fever spirochetes (3). During relapsing fever, a single Vmp is produced at high levels and becomes a dominant antigen of the outer membrane. In contrast, it is not yet clear if OspE
and VlsE are dominant proteins of the spirochetal cell surface during
infection in mammals. Hence, it is premature to conclude that they play
a similar dominant role in immune evasion as has been demonstrated for
the Vmps. The process of immune evasion during infection with the Lyme
disease spirochetes is likely to be multifactorial and may be mediated
by several different genes or gene families.
The ospE gene family is one of three gene families whose
members are flanked at their 5' end by a highly conserved,
promoter-carrying sequence element called the upstream homology box
(UHB) element (1, 2, 5, 11, 21). The focus of this
study is the ospF gene family (designated family 164 by TIGR), which in B. burgdorferi B31MI contains three
members, BBO39, BBR42, and BBM38 (TIGR designations). The members of
this family, their general properties, and alternative nomeclatures
that have been assigned are listed in Table
1. It should be noted that TIGR has
placed a fourth gene in this family, BBS41. However, evolutionary
analyses have suggested that this gene is a peripheral member of the
ospF family (11), and as a result this gene was
not analyzed as part of this report. All of the ospF gene
family members are carried by plasmids belonging to the cp32 plasmid
family (4, 19).
From the variable sequence and molecular properties of the UHB-flanked
genes, we hypothesized that mutational and recombination events occur
frequently in these genes (11, 21), resulting in the
generation of new UHB-flanked gene variants that encode proteins with
altered antigenic characteristics. In an analysis of the
ospE gene family, we demonstrated this hypothesis to be correct (20). Since all of the UHB-flanked genes encode
potentially surface-exposed lipoproteins, it follows that mutational
events in members of the UHB-flanked ospF and 163 gene
families could also lead to the development of new antigenic variants
that could contribute to immune evasion. In addition, differential
expression of UHB-flanked genes could also alter the antigenic
characteristics of the Lyme disease spirochetes. While discrepancies
exist in the literature regarding the expression patterns of the
UHB-flanked genes, it has been clearly demonstrated that the
UHB-flanked genes encode immunogenic proteins that are expressed at
some point during infection (1, 6, 17, 22).
In this report we focus our analyses on the ospF gene family
and have sought to assess the genetic stability of these genes and
their expression patterns during infection. The analyses presented here
demonstrate that the frequency of mutation in these genes is low during
infection in mice. Analyses of the humoral immune response to these
proteins revealed that there is a temporal component to this response,
suggesting that different members of the family are expressed at
different times during infection. These studies shed further light on
the hypothesized role of the OspF protein family during infection and
specifically in immune evasion.
 |
MATERIALS AND METHODS |
Bacterial isolates, cultivation, and experimental infection of
mice.
B. burgdorferi B31MI, kindly provided to us by
MedImmune Inc. (Gaithersburg, Md.), was used for these analyses because
the entire genome sequence has been determined for this isolate
(7). This isolate was cultivated in BSK-H complete medium
(Sigma) at 33°C. We previously confirmed the infectivity of this
clone in C3H-HeJ mice (20). All clonal populations derived
from B31MI used in this study were generated as part of an earlier
analysis of the genetic stability of the ospE genes
(20). To obtain postinfection clonal populations,
subsurface plating of cultures obtained from ear punch biopsies was
performed as previously described (20). The plates were
incubated at 33°C under 3.2% CO2 in a humidified CO2 incubator. Approximately 2 to 3 weeks later, individual
colonies were cored from the plates using a sterile Pasteur pipette.
The colony-containing plugs of agarose were inoculated into 2 ml of complete BSK-H medium and cultivated at 33°C.
PCR analysis of ospF gene family members in clonal
populations of B. burgdorferi B31MI.
To PCR amplify
the ospF gene family members of B. burgdorferi
B31MI and its clonal derivative, isolated genomic DNA (~50 ng) was
used as the template with the primers listed in Table
2. DNA was isolated as previously
described (10). In some cases template DNA was obtained by
collecting well-isolated B. burgdorferi colonies (derived
from spirochete cultures recovered from ear punch biopsies),
transferring them into 2 ml of complete BSK-H medium, and cultivating
them to mid-log phase. Then 100-µl aliquots were removed, and cells
were pelleted, washed with phosphate-buffered saline (PBS), and
resuspended in 100 µl of H2O. The cell suspension was
boiled for 10 min and centrifuged to pellet debris, and 1 µl of the
supernatant was used as the template in PCR. PCR was performed with
Taq polymerase (Promega) for 30 cycles in an MJ Research
PTC100 thermal cycler with a hot bonnet. Reaction volumes were 30 µl,
and final primer set concentrations were 1 pmol of primer pair per
µl. Cycling conditions were as follows: 1 cycle of 5 min at 94°C,
followed by 30 cycles of 1 min at 94°C, 1 min at 50°C and 1.5 min
at 72°C. The resulting amplicons were analyzed by agarose gel
electrophoresis.
Rapid screening for ospF mutations.
ospF-related genes were amplified from B. burgdorferi B31MI and postinfection clonal populations using a
variety of primer sets as described above. As a control for these
analyses, we also amplified and performed single-nucleotide
polymorphism (SNP) analyses on the vlsE gene, which is known
to undergo mutation during infection in mice. The purified
ospF and vlsE amplicons obtained from these clonal populations then served as the template for SNP analyses as
previously described (20). It is important to note that
the vlsE and ospF SNP analyses were performed
using the same set of clones. The SNP approach is essentially a limited
sequencing approach in that only one of the four dideoxynucleotide
incorporation reactions is performed. Comparison of the resulting
ladders on a 6% polyacrylamide-8 M urea sequencing gel provides a
rapid means for screening for mutations. To perform the SNP analyses,
the Excel-Sequencing kit (Epicentre Technologies) and 5'-end,
32P-labeled primers were used.
Cloning and sequence analysis of PCR amplicons.
To determine
the complete sequence of representative ospF gene family
members from different postinfection clonal populations, the amplicons
were TA cloned into the pGEM-T-Easy vector as described by the
manufacturer (Promega). To identify Escherichia coli clones harboring ospF-carrying recombinant (r-) plasmids, the cells
were plated onto Luria-Bertani (LB) plates (amplicillin, 50 µg
ml
1), and individual colonies were picked with sterile
toothpicks and resuspended in 100 µl of distilled H2O.
The resuspended cells were boiled for 10 min, and 1 µl of the cell
lysate was used as the template in PCR with gene-specific PCR primer
sets. R-plasmids carrying the appropriate inserts were used as the
template for sequence analysis. Sequencing was accomplished using
end-labeled primers and the Excel-Sequencing kit as described by the
manufacturer (Epicentre Technologies). Sequencing reactions were run on
6% polyacrylamide-8 M urea gels, and autoradiography was performed. The determined sequences were translated using the Translate program, and both the nucleotide and amino acid sequences were aligned using the
Pileup program and manually adjusted. These programs are contained
within the Wisconsin-GCG sequence analysis package.
Immunoblot procedures and LIC and expression of OspF paralogs:
analysis of humoral immune response to OspF in experimentally infected
mice.
The humoral immune response to OspF variants was assessed by
immunoblotting. The test antigens for these analyses were generated by
PCR amplifying ospF gene family members from B. burgdorferi B31MI-derived clones with primers possessing tail
sequences that complement the single-stranded overhangs of the
ligase-independent cloning (LIC) pT7Blue-2 LIC vector (Novagen). After
PCR was performed, the single-stranded overhangs on the amplicon were
generated by treatment with T4 DNA polymerase in the presence of dATP
(other deoxynucleoside triphosphates are omitted) as described by the manufacturer (Novagen). To summarize, the 3'-to-5' exonuclease activity
of the T4 DNA polymerase will digest the amplicon until it reaches the
first A residue under the reaction conditions described above. The
first A residue in the primers above corresponds to the first base of
the start codon and the last base of the stop codon. When these bases
are encountered by the DNA polymerase, the 5'-3' polymerase activity
counteracts its exonuclease activity, resulting in an amplicon with
single-stranded overhangs that complement the vector. The treated
amplicon and pT7Blue2-LIC vector were then annealed and transformed
into E. coli NovaBlue Singles competent cells (Novagen),
using a standard transformation protocol, where covalent bond formation
occurs and the plasmid is propagated. To identify colonies harboring
the correct r-plasmid, colonies were selected, placed in 100 µl of
H2O (after generating a master plate with all analyzed
colonies), and boiled for 10 min, and 1 µl was used as the template
in PCR with the appropriate primer set. Selected recombinants carrying
the appropriate plasmid were inoculated into 3 ml of LB (ampicillin,
100 µg ml
1) and grown to an optical density at 600 nm
of 0.6, and then protein expression was induced with 0.4 mm IPTG
(isopropylthiogalactoside) for 3 h. The expressed protein
represents a fusion protein with a 62-amino-acid S-Tag fused to its N
terminus. The induced cells were pelleted and cell lysates were
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) on a 15% gel.
To conduct immunoblot analyses, the proteins were transferred from the
gels onto polyvinylidene difluoride (PVDF) by electroblotting using the
Trans-blot system (Bio-Rad) as previously described (15).
To assess the temporal pattern of the immunoglobulin G (IgG) response
to OspF protein family members, immunoblot strips of a blot containing
cell lysates of E. coli expressing r-proteins were used as
the antigenic substrate. All immunoblots were blocked overnight in
blocking buffer (1× PBS, 0.2% Tween, 0.002% NaCl, and 5% nonfat dry
milk) and then incubated with a 1:500 (in blocking buffer) dilution of
either anti-OspF, anti-B. burgdorferi B31MI pc (for parental
clone), anti-B. burgdorferi B31MI c53, anti-B. burgdorferi N40cl, or anti-B. burgdorferi 297cl
antiserum. The anti-S-Tag protein (horseradish peroxidase
[HRP]-conjugated) was used at a dilution of 1:5,000. Prior to use,
the infection antisera were preabsorbed with E. coli DH5
or with E. coli that had been induced to express BBO39 as
follows. The E. coli cells were boiled in PBS for 15 min,
and then an aliquot of the cell lysate was incubated with the diluted
antiserum (in blocking buffer) overnight at 4°C. The sample was
centrifuged to pellet cellular debris and bound antibody, and the
supernatant was recovered. Another aliquot of E. coli was
added, and the samples were incubated for 1 h at room temperature.
The immunoblots were added to the preabsorbed sera, incubated at room
temperature for 1 h, and washed three times with wash buffer (1×
PBS, 0.2% Tween, 0.002% NaCl). For analysis of the IgG response,
ImmunoPure goat anti-mouse IgG (heavy and light chain)
peroxidase-conjugated secondary antibody was used at a dilution of
1:40,000. The secondary antibody was incubated with the blots for
1 h at room temperature and then washed three times with wash
buffer. For chemiluminescent detection, the Supersignal West Pico
stable peroxide solution and the Supersignal West Pico luminol/enhancer
solution were used. Both reagents were from Pierce. The immunoblots
were exposed to film.
 |
RESULTS |
PCR analyses of ospF gene family members in
postinfection clonal populations.
Several studies have
demonstrated that borrelial plasmids can be lost during cultivation
(14, 16) or during infection in mice (12).
Knowledge of the cp32 plasmid composition is essential in order to
accurately interpret the data obtained in the course of this study. To
determine if the plasmids that carry the ospF gene family
members were maintained by the clonal populations analyzed here after
12 weeks of infection in mice, PCR analyses were performed using
plasmid- or gene-specific primers (a comprehensive experimental flow
chart is shown in Fig. 1). Of relevance
to this report are plasmids cp32-4, cp32-6, and cp32-7, which carry the ospF gene family members BBR42, BBM38, and BBO39,
respectively (7). All 30 postinfection clones yielded
BBO39 and BBR42 amplicons, indicating that they carry cp32-4 and cp32-7
(Fig. 2). All but one of the clones was
found to carry cp32-6. Clone 9 was found to have lost cp32-6, as
evidenced by the absence of amplification of BBM38. The absence of
cp32-6 from this clone was confirmed through hybridization analysis in
a separate study (12). Analysis of the size of the
amplicons obtained for each gene from each clonal population revealed
all to be of the predicted size. This observation suggests that
large-scale rearrangements or mutational events did not occur within
these genes during cultivation. However, since small-scale
rearrangements, insertions, and/or deletions would not be detected by
the PCR approach applied above, SNP analyses were performed as
described below.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic of the experimental approach used to assess
the genetic stability of the ospF gene family and humoral
immune response to OspF-related proteins during infection.
|
|

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of the genetic stability of ospF
gene family members in representative postinfection clonal populations
of B. burgdorferi B31MI. PCR and SNP analyses were
performed. (A) PCR analyses of BBR42, BBM38, and BBO39. Cell lysates of
each B. burgdorferi B31MI postinfection clone and the
preinfection parental clone (pc) were used as the template in PCR with
gene-specific primer sets as described in the text. The amplicons were
fractionated in 1% GTG-agarose gels and visualized by staining with
ethidium bromide. Size standards are indicated on the left, and the
gene targeted for amplification is shown on the right. For the SNP
analyses, PCR amplicons for each gene were purified and served as the
SNP template as described in the text. A representative segment of the
SNP analyses of BBO39, conducted to determine if point mutations
developed during infection, is presented in panel B. In addition, a
segment of an SNP analysis of the vlsE gene, which is known
to undergo mutation during infection, is shown. In both panels, the
number designation assigned to each clone analyzed is indicated across
the top of the figure.
|
|
SNP pattern analysis of ospF gene family members in
clonal populations after infection in mice.
SNP analyses offer a
rapid means for assessing whether mutational events have occurred in a
gene of interest. By this approach, one simply compares sequencing
ladders generated using one of the four nucleotides for a series of
templates. In this case, the BB039, BBM38, and BBR42 ddATP ladders,
obtained from the analysis of amplicons derived from a series of 30 postinfection clonal populations, were compared. This approach allows
one to determine if changes have developed among clonal populations in
ospF gene family members during infection in mice. The
clones selected for analysis represent a subset of those that we
characterized previously with regard to the genetic stability of the
ospE genes during infection (20). These
clones were found to either undergo recombination events or develop
mutations in ospE during a 3-month infection time frame
in C3H-HeJ mice. As an additional positive control for our ability to
detect mutations by this approach, we also conducted SNP analyses of
the vlsE gene, which is known to experience mutation
during infection in C3H-HeJ mice (23). In
contrast to the vlsE and ospE genes,
mutations were not detected in the BBR42, BBM38, and BBO39 genes
in these 30 different clonal populations (Fig. 2). From these analyses,
it can be concluded that in B. burgdorferi B31MI, members of
the ospF gene family are genetically stable during infection.
Analysis of humoral immune response to OspF protein family
members.
To allow an assessment of the specificity and development
of the humoral immune response to OspF protein family members, the BBO39, BBM38, and BBR42 genes were PCR amplified using primers generated for LIC cloning and expressed in E. coli. To
verify that the cloned genes were expressed in E. coli,
immunoblot analyses were performed using an S-protein directed against
the S-Tag segment of the r-fusion proteins (Fig.
3). R-proteins of the appropriate size
were detected for each of the constructs, confirming expression. The
relatively equivalent amounts of protein detected in the immunoblot analyses indicate that expression levels were comparable for each. This
observation is of importance for evaluating the data presented below.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoblot analysis of r-OspF protein family members
expressed in E. coli. Each member of the ospF
gene family was cloned and expressed as an S-tag fusion protein using
ligase-independent cloning methods as described in the text. Proteins
from E. coli cultures that were induced to express the
r-proteins with IPTG were fractionated by SDS-PAGE and transferred to a
PVDF membrane by electroblotting. The membrane on the left was screened
with anti-S-Tag protein HRP conjugate, while the membrane on the right
was screened with a polyclonal anti-OspF antiserum (generated with a
gene of B. burgdorferi N40 origin). Immunoblot methods are
described in the text. Molecular size standards are indicated on the
left.
|
|
As one means of assessing the antigenic relatedness of
BBO39, BBM38, and BBR42, we tested the potential
immunoreactivity of each r-protein with anti-OspF antiserum
(9). This polyclonal antiserum, kindly provided by Fikrig
and colleagues, was generated using a purified r-OspF expressed from an
ospF gene family member from B. burgdorferi N40
(9). This r-protein exhibits amino acid identity values
with BBO39, BBR42, and BBM38 of 76.2, 75.7, and 56.6%, respectively.
The test antigens for these immunoblots were lysates of E. coli that had been induced with IPTG to express each r-protein.
The polyclonal anti-OspF antiserum reacted with BBO39 and
BBR42 but not with BBM38 (Fig. 3). This observation demonstrates
that there are shared epitopes among r-forms of BBO39 and BBR42. In
contrast, the lack of reaction with BBM38 indicates that this
protein is antigenically distinct. In light of this observation, it
follows that changes in the expression patterns of the ospF
gene family could lead to changes in the antigenic composition of the
cell. The analyses described below sought to address the possible
temporal expression of these genes during infection.
Analysis of temporal pattern of humoral immune response to OspF
protein family members during infection of C3H-HeJ mice with B. burgdorferi B31MI.
To determine if there is a temporal
aspect to the humoral immune response to OspF-related proteins, serum
samples were collected at 2-week intervals up to 12 weeks from mice
that had been infected by needle inoculation with B. burgdorferi B31MI pc. Lysates of E. coli cells
that had been induced with IPTG to express each r-protein were used as
the test antigen in immunoblot analyses. The serum samples were first
preabsorbed with E. coli DH5
cells. Immunoblot analyses
using sera from two mice revealed a weak IgG response to BBO39 by week
4 of infection (data not shown) and a strong response by week 6 (Fig.
4). BBR42 was found to be only weakly
immunoreactive, while BBM38 was not reactive with these infection-derived sera even after 12 weeks of infection. The absence of
an early response to BBR42 and BBM38 in both mice suggests that, in
contrast to BBO39, these proteins are not expressed during early
infection. An alternative interpretation is that BBR42 and BBM38 are
expressed but that these proteins are only weakly immunogenic. However,
earlier studies have demonstrated that the OspE-, and OspF-related
proteins are immunogenic in mice (1, 6, 9, 13, 17, 22).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of temporal pattern and specificity of the
humoral response to OspF protein family members during murine
infection. Cell lysates of E. coli that were induced to
express the r-proteins (as labeled in the figure) with IPTG were
fractionated by SDS-PAGE and immunoblotted. Identical membranes were
screened with infection-derived sera from mice infected with either
B. burgdorferi B31MI pc (A) or B. burgdorferi
B31MI c53 (B). In addition, as shown in panel B, the infection sera
were also preabsorbed with a lysate of E. coli that had been
induced to express r-BBO39. m1 and m2 indicate the specific mouse from
which the serum was collected. The time after initial infection at
which the sera were collected is indicated. The asterisk indicates that
infection serum pc-m2 was actually collected at week 10 (not week
12).
|
|
The demonstration of a delayed antibody response to BBR42 and BBM38 in
both mice tested indicates that this phenomenon is not unique to an
individual mouse. Nonetheless, to further investigate the temporal
aspect of expression, additional confirmatory experiments were
performed. The antibody response to these proteins was assessed in two
mice infected with c53 (a clone recovered from an ear punch biopsy from
a mouse infected with B. burgdorferi B31MIpc). Serum samples
were collected at 2-week intervals from each mouse up to 12 weeks
postinfection. The identical cell lysates used in the analyses
described above again served as the test antigen in these immunoblot
analyses. Screening of the immunoblots with these infection-derived
sera revealed that an IgG response to BBO39 but not BBM38 and BBR42
could be detected as early as week 4 (data not shown) and intensified
by week 6 (Fig. 4). However, as in the mice infected with B31MI pc,
there was no detectable response to BBM38 and only a weak response to
BBR42 by week 6. IgG antibodies that recognize BBM38 were detected but
not until 12 weeks postinfection, supporting the suggestion that this
gene is not expressed during early infection. While the precise
timepoints at which a given protein elicited a specific antibody
response differed slightly in mice infected with either pc or c53, it
is evident that the general trends remain.
Analysis of specificity of antibody response to BBM38 and
BBR42.
The experiments above demonstrated that in some mice, an
antibody response to BBM38 and BBR42 does not develop until late stages
of infection. It is possible that the immunoreactivity of BBM38 and
BBR42 with the late stage infection sera could be due to an expansion
of the antibody response to BBO39, resulting in cross-immunoreactivity
of anti-BBO39 antibodies with these proteins. To test for this
possibility, immunoblots of the r-proteins were screened with the
infection sera from mice infected with B31MI c53 that had been
preabsorbed with lysates of E. coli that had been induced to
express BBO39 (Fig. 4). Preabsorption eliminated immunoreactivity with
rBBO39 but had no effect on the immunoreactivity of BBR42 and BBM38.
These analyses demonstrate that the antibodies that develop late in
infection to BBO39 and BBR42 are in fact specific for these proteins
and are not cross-reactive antibodies. This observation provides
further evidence for the late-stage-specific expression of BBM38 and
BBR42 during infection.
Analysis of antibody response to OspF protein family members in
mice infected with B. burgdorferi N40 and 297.
To
determine if other isolates express antigenically related proteins and
exhibit a similar temporal pattern of expression, mice were infected
with clones of B. burgdorferi N40 and 297 (N40c1 and 297c1,
respectively). It is important to note that the genome sequence for
these isolates has not been determined, and as a result the composition
of the ospF gene family in these isolates has not been fully
defined. This is an unavoidable caveat in analyses that deal with
isolates other than B31MI. The first step in these analyses was to
determine if these isolates carry genes related to BBO39, BBR42, and
BBM38. Towards this goal, PCR analyses were performed. PCR
amplification was observed with both N40 and 297 using the
BBO39-(strong amplification) and BBR42 (moderate
amplification)-specific primer sets (data not shown). For BBM38, strong
amplification was observed with isolate 297, while no product was
obtained from isolate N40. Hence, it appears either that N40 lacks
BBM38 or that its sequence is divergent enough that amplification will not occur with the primer set used. In any event, these analyses indicate that the clones of isolates 297 and N40 used here carry sequences related to at least some of these genes.
To conduct the immunoblot analyses, serum samples were collected from
the infected mice at 2 week intervals up to 12 weeks postinfection, and
immunoblots identical to those described above were screened with
the infection-derived sera (Fig. 5). The
sera from these mice collected 8 weeks into infection reacted
strongly with BBO39, indicating that the time frame for induction of an anti-BBO39 IgG response is similar in mice infected with these heterologous strains (note that sera from week 6 of infection were not
available for analysis). It can be concluded that N40 and 297 express
an OspF-related protein that has epitopes in common with BBO39 of
B. burgdorferi B31MI. Regarding BBM38 and BBR42, consistent
with the trends observed in the mice infected with B. burgdorferi B31MI pc and c53, an IgG response to these proteins was not observed through 12 weeks of infection. The absence of an
antibody response to BBM38 and BBR42 in the sera of mice infected with
N40 or 297 could be due to several possibilities. There could be
significant sequence divergence in these proteins or, as observed in
the B31MI-infected mice, the expression of these proteins could be
repressed during infection.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 5.
Analysis of murine humoral immune response to OspF
protein family members in mice infected with heterologous strains.
Immunoblots of the r-proteins were generated as described for Fig. 4.
The immunoblots were screened with sera collected at either 0, 8, or 12 weeks after inoculation. The mice were infected for 12 weeks with
either B. burgdorferi N40 c1 and B. burgdorferi
297 c1.
|
|
 |
DISCUSSION |
Evolutionary analyses have demonstrated that B. burgdorferi B31MI carries three well-defined UHB-flanked gene
families, ospE, ospF, and family 163 (2,
11). The focus of this report is the ospF gene
family, which in B. burgdorferi B31MI comprises three
members: BBR42, BBO39, and BBM38 (7). Comparative analyses of ospF-related genes from different isolates have
demonstrated that these genes are highly variable, suggesting recent
modification by mutational and recombination events (11, 18,
21). Based on this observation and our earlier work that
demonstrated that the UHB-flanked ospE gene family
undergoes mutation and recombination during infection
(20), we hypothesized that similar molecular events occur
in the ospF gene family during infection. One possible consequence of these processes could be the generation of antigenic variants that contribute to immune evasion. To test this hypothesis, we
analyzed the genetic stability and humoral immune response to
individual members of the OspF protein family using the murine model
for Lyme disease. Analyses of ospF genetic stability focused on a series of B. burgdorferi clones recovered from C3H-HeJ
mice that had been infected for 12 weeks with B. burgdorferi
B31MI (20). The clonal populations analyzed in this report
were the same populations previously found to undergo mutation in their ospE genes. In this report, we also demonstrate that
mutations develop within the vlsE gene of these clones
during infection. However, in contrast to ospE and
vlsE, SNP analyses of BBO39, BBR42, and BBM38 revealed that
the frequency of mutation in these genes during infection is low. As an
additional means for testing for the development of mutations, complete
sequence analysis of several of the ospF gene family member
PCR amplicons was performed. As with the SNP analyses, mutations were
not detected. In an earlier analysis, we demonstrated that BBS41 (a
peripheral member of the ospF family) is also stable during
infection (20). The absence of mutation in the
ospF gene family members and the peripherally related BBS41
gene, in a background that is known to undergo mutation during
infection, indicates that ospF gene family members are stable during infection in mice.
Prior to this report, little was known about the patterns of expression
of the OspF protein family during infection. As a means of assessing
the expression patterns and to characterize the specificity of the
humoral response, each of the ospF family members from
B. burgdorferi B31MI was cloned and expressed in E. coli for use in immunoblot analyses. After confirming that the
constructs were expressed at similar levels in E. coli, the r-proteins were screened with a polyclonal anti-OspF antiserum generated using r-protein of B. burgdorferi N40 origin
(9). This antiserum recognized r-forms of BBO39 and BBR42
but not BBM38, indicating that BBM38 is antigenically distinct from
other OspF family member proteins.
To assess the expression patterns and the specificity of the immune
response to the OspF proteins during infection, immunoblots of these
proteins were screened with infection sera from several mice that were
collected over the course of infection. Sera collected after 6 weeks of
infection from mice infected with B. burgdorferi B31MI pc
were found to possess antibodies to BBO39 but not to BBR42 or BBM38.
This observation demonstrates that anti-BBO39 antibodies are not
immunologically cross-reactive with BBM38 or BBR42. A significant
response to BBM38 and BBR42 did not develop in any of the B31MI
pc-infected mice analyzed, even after 12 weeks of infection. A similar
trend was also observed in the mice infected with B. burgdorferi B31MI c53. While a strong IgG response did develop by
week 12 in c53-infected mice, it is clear from both experiments that a
significant IgG response to BBR42 and BBM38 develops considerably later
than to BBO39. As all OspF-related proteins that have been analyzed to
date have been demonstrated to be immunogenic in mice
(17), it is possible that the delayed response to BBR42
and BBM38 results from the temporal expression of these proteins during
infection. One possible explanation for the detection of antibodies to
BBR42 and BBM38 in the B31MI c53-infected mice was that there is some
degree of cross-reactivity of the anti-BBO39 antibodies with these
proteins. However, preabsorption of these infection sera with lysates
of E. coli that had been induced to express BBO39 confirmed
that the IgG response to these proteins was specific and not due to
cross-reactivity.
To determine if infection with other isolates results in the late-stage
production of antibodies that recognize BBO39, BBR42, or BBM38, mice
were infected with the B. burgdorferi isolates N40 and 297. During the early stages of infection, these mice produced antibodies
that recognize r-BBO39 but not BBR42 or BBM38. The absence of
antibodies to BBR42 and BBM38 in sera collected during early infection
suggests either that these proteins are not expressed or that 297 and
N40 encode variants of these proteins that are antigenically distinct
from that carried by B31MI. Immunoblot analyses of late-stage infection
sera revealed that mice infected with N40 but not 297 develop
anti-BBR42 antibodies. As in the mice infected with B31MI clones pc and
c53, the antibody response to these proteins suggests temporal
expression of BBR42. Antibodies to BBM38 were not detected in any of
the serum samples from the N40- or 297-infected mice. As described
above, we were able to amplify BBO39 and BBR42 from both 297 and N40
but could only amplify BBM38 from isolate 297. The absence of
antibodies to BBM38 and BBR42 in the 297 infection sera may indicate
that these proteins are not expressed by this isolate during infection
or that they are expressed at a time point later than 12 weeks. Since
BBM38 could not be amplified from isolate N40, no conclusion can be reached at this time about the lack of anti-BBM38 antibodies in the N40
infection-derived sera.
The apparent temporal expression of BBR42 and BBM38 during infection is
consistent with and may explain some earlier data reported by Nguyen et
al (13). It was demonstrated that antibodies to an
OspF-related protein of N40 could be detected in only 14% of Lyme
disease patients with "early Lyme disease." In contrast, an
antibody response to OspF was detected in 58% of the patients with
late Lyme disease. It was also demonstrated that antibodies to B. burgdorferi N40 OspF did not develop in mice infected with N40
until 90 days into the infection. The time frame of development of the
humoral immune response to OspF-related proteins in this earlier report
is consistent with that reported here for BBR42 and BBM38. At the time
that Nguyen et al. conducted their analyses, a completed genome
sequence for B. burgdorferi was not available, and it had
not yet been demonstrated that OspF belongs to a paralogous protein
family. As a result, it was not possible for those authors to
specifically determine which ospF allele(s) was or was not being expressed. By exploiting the genome sequence, we have been able
to demonstrate which specific members of the OspF family are expressed
at which relative stages of infection.
In an earlier analysis, Stevenson et al. reported that an IgG response
to the OspF family members BBO39 and BBM38 could be detected in a mouse
infected with B. burgdorferi for 4 weeks (17). Consistent with this, we also detected an IgG response to BBO39 during
early infection. However, in contrast, we did not detect an early IgG
response to BBM38. The observed immunoreactivity of r-BBM38 (referred
to as ErpK in the aforementioned study) noted by Stevenson et al. was
relatively weak, and the size of the immunoreactive protein was not
consistent with that predicted for BBM38. A second important point is
that upon analysis of serum samples from human Lyme disease patients,
Stevenson et al. reported that only 2 of the 10 patient sera analyzed
had anti-BBM38 antibodies. This observation may be inconsistent with
the authors' conclusion that all OspE- and OspF-related proteins are
expressed early during infection. It is possible that the absence of a
detectable response to BBM38 in these human serum samples could reflect
the time point at which the sera were collected. The data presented
here would suggest that if the sera were collected during early
infection, an IgG response to BBM38 might not be observed due to the
expression of this gene during later stages of infection.
Unfortunately, the time point during infection at which the human sera
were collected was not known to the authors, and hence it is not
possible to further assess these earlier data. The basis for the
discrepancies regarding the expression patterns of the OspF proteins
reported here and by Nguyen et al. (13) with that reported
by Stevenson and colleagues is unclear. Note that BBR42 expression was
not specifically analyzed by Stevenson et al., and hence we cannot compare and contrast data regarding the expression of this specific protein.
In an attempt to identify the potential molecular basis for the
differential expression of BBO39, BBR42, and BBM38, the UHB elements
for these genes, which harbor the promoter elements, were aligned and
compared (Fig. 6). A 192-nucleotide
stretch located upstream from the translational start codon of BBM38
and BBR42 exhibits 93.7 and 80% identity, respectively, with that of
BBO39. In addition, although the precise locations of the
35 and
10 elements have not been experimentally defined, a putative consensus
10 is evident in all. A 30-nucleotide stretch immediately upstream of
the
10 exhibits only minor sequence variation. Nonetheless, it is
possible that these minor sequence changes could influence the
transcription of these genes. It is also possible that all of the OspF
genes, including BBM38 and BBR42, are transcribed during early
infection but that protein production is posttranscriptionally regulated. Recent findings by Hefty et al. suggest that some
UHB-flanked genes of B. burgdorferi 297 are transcribed in
the mammal but that protein production is posttranscriptionally
repressed (8). The precise mechanism(s) by which temporal
transcription or protein production occurs will require further
experimentation and analysis. In closing, the data presented here
further illustrate the dynamics of protein expression in Lyme disease
spirochetes. The study of the temporal component of protein expression
will provide significant insight into the nature of the host-pathogen
relationship over the course of disease.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 6.
Alignment of UHBs of B. burgdorferi B31MI
ospF gene family members. The sequences were obtained from
the genome sequence of B. burgdorferi B31MI and aligned, and
the alignment was manually refined. The putative translational start
codons and 10 and 35 elements are indicated. Note that two
translational start codons are indicated for BBM38. The more upstream
ATG listed by TIGR as the start codon is likely to be incorrect, as
there is no ribosome-binding site (RBS) upstream from this codon.
However, a second ATG resides 12 bp downstream, and this start is
preceded by a consensus ribosome-binding site. Note that BBR42 is the
downstream gene in an operon with BBF40. BBR42 itself is not 5' flanked
by a UHB element; hence, the UHB element flanking BBR40 is shown.
|
|
 |
ACKNOWLEDGMENTS |
We thank Darrin Akins and Scott Hefty for helpful discussions and
for sharing data prior to publication. In addition, we thank the
Molecular Pathogenesis Group at Virginia Commonwealth University for
insightful comments and advice.
This work was supported in parts by grants from Virginia's
Commonwealth Health Research Board, the Jeffress Trust, and the National Institutes of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 23298-0678, Phone: (804) 828-3779. Fax: (804) 828-9946. E-mail:
rmarconi{at}hsc.vcu.edu.
Editor:
V. J. DiRita
 |
REFERENCES |
| 1.
|
Akins, D.,
S. F. Porcella,
T. G. Popova,
D. Shevchenko,
S. I. Baker,
M. Li,
M. V. Norgard, and J. D. Radolf.
1995.
Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue.
Mol. Microbiol.
18:507-520[CrossRef][Medline].
|
| 2.
|
Akins, D. R.,
M. J. Caimano,
X. Yang,
F. Cerna,
M. V. Norgard, and J. D. Radolf.
1999.
Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides.
Infect. Immun.
67:1526-1532[Abstract/Free Full Text].
|
| 3.
|
Barbour, A. G.
1990.
Antigenic variation of a relapsing fever Borrelia species.
Annu. Rev. Microbiol.
44:155-171[CrossRef][Medline].
|
| 4.
|
Casjens, S.,
N. Palmer,
R. van Vugt,
W. M. Huang,
B. Stevenson,
P. Rosa,
R. Lathigra,
G. Sutton,
J. Peterson,
R. J. Dodson,
D. Haft,
E. Hickey,
M. Gwinn,
O. White, and C. M. Fraser.
2000.
A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi.
Mol. Microbiol.
35:490-516[CrossRef][Medline].
|
| 5.
|
Casjens, S.,
R. van Vugt,
K. Tilly,
P. A. Rosa, and B. Stevenson.
1997.
Homology throughout the multiple 32 kilobase circular plasmids in Lyme disease spirochetes.
J. Bacteriol.
179:217-227[Abstract/Free Full Text].
|
| 6.
|
Das, S.,
S. W. Barthold,
S. S. Giles,
R. R. Montgomery,
S. R. Telford III, and E. Fikrig.
1997.
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
J. Clin. Investig.
99:987-995[Medline].
|
| 7.
|
Fraser, C.,
S. Casjens,
W. M. Huang,
G. G. Sutton,
R. Clayton,
R. Lathigra,
O. White,
K. A. Ketchum,
R. Dodson,
E. K. Hickey,
M. Gwinn,
B. Dougherty,
J. F. Tomb,
R. D. Fleischman,
D. Richardson,
J. Peterson,
A. R. Kerlavage,
J. Quackenbush,
S. Salzberg,
M. Hanson,
R. Vugt,
N. Palmer,
M. D. Adams,
J. Gocayne,
J. Weidman,
T. Utterback,
L. Watthey,
L. McDonald,
P. Artiach,
C. Bowman,
S. Garland,
C. Fujii,
M. D. Cotton,
K. Horst,
K. Roberts,
B. Hatch,
H. O. Smith, and J. C. Venter.
1997.
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.
Nature
390:580-586[CrossRef][Medline].
|
| 8.
|
Hefty, P. S.,
S. E. Jolliff,
M. J. Caimano,
S. K. Wikel,
J. D. Radolf, and J. R. Akins.
2001.
Regulation of the OspE-related, OspF-related, and Elp lipoproteins of Borrelia burgdorferi strain 297 by mammalian host-specific signals.
Infect. Immun.,
69:3618-3627[Abstract/Free Full Text].
|
| 9.
|
Lam, T. T.,
T.-P. K. Nguyen,
R. R. Montgomery,
F. S. Kantor,
E. Fikrig, and R. A. Flavell.
1994.
Outer surface protein E and F of Borrelia burgdorferi, the agent of Lyme disease.
Infect. Immun.
62:290-298[Abstract/Free Full Text].
|
| 10.
|
Marconi, R. T.,
D. S. Samuels, and C. F. Garon.
1993.
Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes.
J. Bacteriol.
175:926-932[Abstract/Free Full Text].
|
| 11.
|
Marconi, R. T.,
S. Y. Sung,
C. N. Hughes, and J. A. Carlyon.
1996.
Molecular and evolutionary analyses of a variable series of genes in Borrelia burgdorferi that are related to ospE and ospF, constitute a gene family, and share a common upstream homology box.
J. Bacteriol.
178:5615-5626[Abstract/Free Full Text].
|
| 12.
|
McDowell, J. V.,
J. T. Skare,
S.-Y. Sung, and R. T. Marconi.
2001.
Analysis of mechanisms associated with the loss of infectivity of clonal populations of Borrelia burgdorferi B31MI.
Infect. Immun.,
69:3670-3677[Abstract/Free Full Text].
|
| 13.
|
Nguyen, T.-P. K.,
T. T. Lam,
S. W. Barthold,
S. R. Telford III,
R. A. Flavell, and E. Fikrig.
1994.
Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice.
Infect. Immun.
62:2079-2084[Abstract/Free Full Text].
|
| 14.
|
Purser, J. E., and S. J. Norris.
2000.
Correlation between plasmid content and infectivity in Borrelia burgdorferi.
Proc. Natl. Acad. Sci. USA
97:13865-13870[Abstract/Free Full Text].
|
| 15.
|
Roberts, D. M.,
J. A. Carlyon,
M. Theisen, and R. T. Marconi.
2000.
The bdr gene families of the Lyme disease and relapsing fever spirochetes: possible influence on biology, pathogenesis and evolution.
Emerg. Infect. Dis.
6:110-122[Medline].
|
| 16.
|
Schwan, T. G.,
W. Burgdorfer, and C. F. Garon.
1988.
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.
Infect. Immun.
56:1831-1836[Abstract/Free Full Text].
|
| 17.
|
Stevenson, B.,
J. L. Bono,
T. G. Schwan, and P. Rosa.
1998.
Borrelia burgdorferi Erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria.
Infect. Immun.
66:2648-2654[Abstract/Free Full Text].
|
| 18.
|
Stevenson, B.,
S. Casjens, and P. Rosa.
1998.
Evidence of past recombination events among the genes encoding Erp antigens of Borrelia burgdorferi.
Microbiology
144:1869-1879[Abstract/Free Full Text].
|
| 19.
|
Stevenson, B.,
K. Tilly, and P. A. Rosa.
1996.
A family of genes located on four separate 32 kilobase circular plasmids in Borrelia burgdorferi B31.
J. Bacteriol.
178:3508-3516[Abstract/Free Full Text].
|
| 20.
|
Sung, S. Y.,
J. McDowell,
J. A. Carlyon, and R. T. Marconi.
2000.
Mutation and recombination in the upstream homology box flanked ospE related genes of the Lyme disease spirochetes results in the development of new antigenic variants during infection.
Infect. Immun.
68:1319-1327[Abstract/Free Full Text].
|
| 21.
|
Sung, S.-Y.,
C. LaVoie,
J. A. Carlyon, and R. T. Marconi.
1998.
Genetic divergence and evolutionary instability in ospE-related members of the upstream homology box gene family in Borrelia burgdorferi sensu lato complex isolates.
Infect. Immun.
66:4656-4668[Abstract/Free Full Text].
|
| 22.
|
Wallich, R.,
C. Brenner,
M. D. Kramer, and M. M. Simon.
1995.
Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.
Infect. Immun.
63:3327-3335[Abstract].
|
| 23.
|
Zhang, J.-R.,
J. M. Hardham,
A. G. Barbour, and A. G. Norris.
1997.
Antigenic variation in Lyme disease borreliae by promiscuous recombination of vmp like sequence cassettes.
Cell
89:275-285[CrossRef][Medline].
|
Infection and Immunity, August 2001, p. 4831-4838, Vol. 69, No. 8
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4831-4838.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gilmore, R. D. Jr., Howison, R. R., Schmit, V. L., Nowalk, A. J., Clifton, D. R., Nolder, C., Hughes, J. L., Carroll, J. A.
(2007). Temporal Expression Analysis of the Borrelia burgdorferi Paralogous Gene Family 54 Genes BBA64, BBA65, and BBA66 during Persistent Infection in Mice. Infect. Immun.
75: 2753-2764
[Abstract]
[Full Text]
-
Hovis, K. M., Tran, E., Sundy, C. M., Buckles, E., McDowell, J. V., Marconi, R. T.
(2006). Selective Binding of Borrelia burgdorferi OspE Paralogs to Factor H and Serum Proteins from Diverse Animals: Possible Expansion of the Role of OspE in Lyme Disease Pathogenesis. Infect. Immun.
74: 1967-1972
[Abstract]
[Full Text]
-
von Lackum, K., Miller, J. C., Bykowski, T., Riley, S. P., Woodman, M. E., Brade, V., Kraiczy, P., Stevenson, B., Wallich, R.
(2005). Borrelia burgdorferi Regulates Expression of Complement Regulator-Acquiring Surface Protein 1 during the Mammal-Tick Infection Cycle. Infect. Immun.
73: 7398-7405
[Abstract]
[Full Text]
-
McDowell, J. V., Harlin, M. E., Rogers, E. A., Marconi, R. T.
(2005). Putative Coiled-Coil Structural Elements of the BBA68 Protein of Lyme Disease Spirochetes Are Required for Formation of Its Factor H Binding Site. J. Bacteriol.
187: 1317-1323
[Abstract]
[Full Text]
-
Zhang, H., Raji, A., Theisen, M., Hansen, P. R., Marconi, R. T.
(2005). bdrF2 of Lyme Disease Spirochetes Is Coexpressed with a Series of Cytoplasmic Proteins and Is Produced Specifically during Early Infection. J. Bacteriol.
187: 175-184
[Abstract]
[Full Text]
-
Hovis, K. M., McDowell, J. V., Griffin, L., Marconi, R. T.
(2004). Identification and Characterization of a Linear-Plasmid-Encoded Factor H-Binding Protein (FhbA) of the Relapsing Fever Spirochete Borrelia hermsii. J. Bacteriol.
186: 2612-2618
[Abstract]
[Full Text]
-
Babb, K., McAlister, J. D., Miller, J. C., Stevenson, B.
(2004). Molecular Characterization of Borrelia burgdorferi erp Promoter/Operator Elements. J. Bacteriol.
186: 2745-2756
[Abstract]
[Full Text]
-
Miller, J. C., von Lackum, K., Babb, K., McAlister, J. D., Stevenson, B.
(2003). Temporal Analysis of Borrelia burgdorferi Erp Protein Expression throughout the Mammal-Tick Infectious Cycle. Infect. Immun.
71: 6943-6952
[Abstract]
[Full Text]
-
Metts, M. S., McDowell, J. V., Theisen, M., Hansen, P. R., Marconi, R. T.
(2003). Analysis of the OspE Determinants Involved in Binding of Factor H and OspE-Targeting Antibodies Elicited during Borreliaburgdorferi Infection in Mice. Infect. Immun.
71: 3587-3596
[Abstract]
[Full Text]
-
McDowell, J. V., Wolfgang, J., Tran, E., Metts, M. S., Hamilton, D., Marconi, R. T.
(2003). Comprehensive Analysis of the Factor H Binding Capabilities of Borrelia Species Associated with Lyme Disease: Delineation of Two Distinct Classes of Factor H Binding Proteins. Infect. Immun.
71: 3597-3602
[Abstract]
[Full Text]
-
Roberts, D. M., Caimano, M., McDowell, J., Theisen, M., Holm, A., Orff, E., Nelson, D., Wikel, S., Radolf, J., Marconi, R. T.
(2002). Environmental Regulation and Differential Production of Members of the Bdr Protein Family of Borrelia burgdorferi. Infect. Immun.
70: 7033-7041
[Abstract]
[Full Text]
-
Stevenson, B.
(2002). Borrelia burgdorferi erp (ospE-Related) Gene Sequences Remain Stable during Mammalian Infection. Infect. Immun.
70: 5307-5311
[Abstract]
[Full Text]
-
McDowell, J. V., Sung, S.-Y., Hu, L. T., Marconi, R. T.
(2002). Evidence That the Variable Regions of the Central Domain of VlsE Are Antigenic during Infection with Lyme Disease Spirochetes. Infect. Immun.
70: 4196-4203
[Abstract]
[Full Text]